Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors
- PMID: 19050963
- DOI: 10.1245/s10434-008-0251-1
Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors
Abstract
Incidence of neuroendocrine tumors (NETs) is increasing (approximately 6%/year), but clinical presentation is nonspecific, resulting in delays in diagnosis (5-7 years; approximately 70% have metastases). This reflects absence of a sensitive plasma marker. The aim of this study is to investigate whether detection of circulating messenger RNA (mRNA) alone or in combination with circulating NET-related hormones and growth factors can detect gastrointestinal NET disease. The small intestinal (SI) NET cell line KRJ-I was used to define the sensitivity of real-time polymerase chain reaction (PCR) for mRNA detection in blood. NSE, Tph-1, and VMAT ( 2 ) transcripts were identified from one KRJ-I cell/ml blood. mRNA from the tissue and plasma of SI-NETs (n = 12) and gastric NETs (n = 7), and plasma from healthy controls (n = 9) was isolated and real-time PCR performed. Tph-1 was a specific marker of SI-NETs (58%, p < 0.03) whereas CgA transcripts did not differentiate tumors from controls. Patients with metastatic disease expressed more marker transcripts than localized tumors (75% versus 18%, p < 0.02). Plasma 5-hydroxytryptamine (5-HT), chromogranin A (CgA), ghrelin, and connective tissue growth factor (CTGF) fragments were measured, combined with mRNA levels, and a predictive mathematical model for NET diagnosis developed using decision trees. The sensitivity and specificity to diagnose SI-NETs and gastric NETs were 81.2% and 100%, and 71.4% and 55.6%, respectively. We conclude that mRNA from one NET cell/ml blood can be detected. Circulating plasma Tph-1 is a promising marker gene for SI-NET disease (specificity 100%) while an increased number of marker transcripts (>2) correlated with disease spread. Including NET-related circulating hormones and growth factors in the algorithm increased the sensitivity of detection of SI-NETs from 58 to 82%.
Similar articles
-
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.PLoS One. 2010 Dec 30;5(12):e16010. doi: 10.1371/journal.pone.0016010. PLoS One. 2010. PMID: 21209860 Free PMC article.
-
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.Eur J Nucl Med Mol Imaging. 2016 May;43(5):839-851. doi: 10.1007/s00259-015-3250-z. Epub 2015 Nov 23. Eur J Nucl Med Mol Imaging. 2016. PMID: 26596723
-
Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.Ann Surg. 2006 Feb;243(2):273-80. doi: 10.1097/01.sla.0000197734.28551.0f. Ann Surg. 2006. PMID: 16432362 Free PMC article.
-
Chromogranin A: any relevance in neuroendocrine tumors?Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):28-37. doi: 10.1097/MED.0000000000000215. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26627724 Review.
-
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis.Pancreas. 2018 Nov/Dec;47(10):1249-1255. doi: 10.1097/MPA.0000000000001184. Pancreas. 2018. PMID: 30325865
Cited by
-
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Endocrine. 2012 Feb;41(1):40-52. doi: 10.1007/s12020-011-9562-2. Epub 2011 Nov 29. Endocrine. 2012. PMID: 22124940 Review.
-
Epithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer.Br J Cancer. 2012 May 22;106(11):1735-41. doi: 10.1038/bjc.2012.82. Epub 2012 Apr 26. Br J Cancer. 2012. PMID: 22538975 Free PMC article.
-
Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.Rev Endocr Metab Disord. 2019 Sep;20(3):333-351. doi: 10.1007/s11154-019-09508-w. Rev Endocr Metab Disord. 2019. PMID: 31368038 Review.
-
The use of biomarkers in neuroendocrine tumours.Frontline Gastroenterol. 2013 Jul;4(3):175-181. doi: 10.1136/flgastro-2012-100272. Epub 2013 Mar 21. Frontline Gastroenterol. 2013. PMID: 28839724 Free PMC article. Review.
-
Technical Aspects of Nominal Partitions on Accuracy of Data Mining Classification of Intestinal Microbiota - Comparison between 7 Restriction Enzymes.Biosci Microbiota Food Health. 2014;33(3):129-38. doi: 10.12938/bmfh.33.129. Epub 2014 May 16. Biosci Microbiota Food Health. 2014. PMID: 25032086 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous